The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Calculate the composition of a PN solution based on the practitioner’s PN order
Predict the suitability of a PN solution given patient specific parameters
Describe the complications that can occur if an unstable PN solution is infused and identify ways to prevent complications
Speaker(s):
Mary
Baker,
PharmD, MBA,
Director, Medical Services,
Hospira, Inc.
Todd
Canada,
PharmD, BCNSP, BCCCP, FASHP, FTSHP,
Nutrition Support Team Coordinator,
University of Texas MD Anderson Cancer Center, Division of Pharmacy, Houston, TX
Don
Filibeck,
PharmD, MBA,
Vice President, Pharmacy Operations,
Axelacare Health Solutions
Eric
Frankel,
MSE, PharmD, BCNSP,
Metabolic Support Service & Neonatal Clinical Lead Pharmacist,
Truman Medical Center, Kansas City, MO
Kathleen
Gura,
PharmD, BCNSP, FASHP, FPPAG, FASPEN, FMSHP,
Pharmacy Clinical Research Program Manager; Assistant Professor of Pediatrics, Pharmacy,
Boston Children’s Hospital, Boston, MA
Mark
Klang,
RPh, MS, BCNSP, FASPEN, PhD,
Core Manager, Research Pharmacy,
Memorial Sloan Kettering Cancer Center, New York, NY
Carol
Rollins,
PharmD, MS, RD, BCNSP, FASHP, FASPEN,
Clinical Professor,
Pharmacy Practice and Science, University of Arizona College of Pharmacy, Tucson, AZ